A Rapid Pharmacokinetic Trial of the Bioavailability of Four MK-1439 Nano Formulations in Healthy Adults
Phase of Trial: Phase I
Latest Information Update: 29 Jan 2016
At a glance
- Drugs Doravirine (Primary) ; Doravirine
- Indications HIV-1 infections
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 08 Jan 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 26 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 30 Sep 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.